Haemonetics | HAE - Vertriebs- Und Verwaltungskosten

Aktienkurs
59.93
Täglich Wechseln
0.31 0.52%
Monatlich
7.15%
Jährlich
-4.13%
Q2 Prognose
58.65




Vertriebs- Und Verwaltungskosten Veränderung Datum
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cerus USD 19.33M 1.55M 2024-12
Cooper Companies USD 373.1M 46.1M 2025-12
Fresenius EUR 819M 143M 2025-12
Fresenius Medical Care EUR 785M 79.56M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
ICU Medical USD 155.81M 3.04M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Neogen USD 98.5M 9M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Plus Therapeutics USD 3.49M 559K 2025-12
Quidel USD 194.4M 7.5M 2025-12
ResMed USD 278.4M 19.2M 2025-12
STAAR Surgical USD 38.94M 20.44M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Surmodics USD 11.4M 3.18M 2025-06
Teleflex USD 222.37M 59.4M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
US Physical Therapy USD 18.12M 711K 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12